Picture of Newron Pharmaceuticals SpA logo

NWRN — Newron Pharmaceuticals SpA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Swiss stocks - Factors to watch on March 22

ZURICH, March 22 (Reuters) - The following are some of the 
main factors expected to affect Swiss stocks on Wednesday: 
      
    CREDIT SUISSE  CSGN.S  
    Credit Suisse will say as soon as possible whether it will 
go ahead with plans to float a minority stake of its Swiss bank, 
Chief Executive Tidjane Thiam told Swiss paper Finanz und 
Wirtschaft, adding the bank still needs more capital. "We're 
still analysing," Thiam said in the interview published late on 
Tuesday. "We have a broad palette of options after our 
settlement with the U.S. Department of Justice. We will 
communicate further details as soon as possible."  urn:newsml:reuters.com:*:nL5N1GY5YG 
    For more click on  CSGN.S  
     
    RICHEMONT  CFR.S  
    French luxury group Kering  PRTP.PA  said on Tuesday that 
its Kering Eyewear unit and Richemont-owned  CFR.S  Maison 
Cartier will partner to develop, manufacture and distribute 
worldwide the Cartier eyewear collection. Under the deal, 
Richemont will buy a 30 percent stake in Kering 
Eyewear. urn:newsml:reuters.com:*:nL5N1GY52S 
    For more click on  CFR.S  
     
    NEWRON  PHARMACEUTICALS  NWRN.S   
    Newron said it would accelerate the U.S. launch of Xadago 
(safinamide) after the U.S. Food and Drug Administration 
approved its Parkinson's disease treatment as an add-on therapy 
to levodopa, a drug widely used to treat the disease. 
 urn:newsml:reuters.com:*:nL3N1GY4TG 
    For more click on  NWRN.S  
 
    COMPANY STATEMENTS  CPR-CH  
    * Meyer Burger  MBTN.S  is targeting a similar level of net 
sales in 2017 as in the previous year and a substantial 
improvement in profitability after hitting a 97.1 million franc 
loss in 2016.  MBTN.S  
    * Schaffner Group  SAHN.S  expects higher earnings before 
interest and tax and stable sales development in the first half 
of its 2016-17 reporting year, the group said on Wednesday. Its 
half-year report is due for release on May 11.  SAHN.S  
    * U Blox Holding  UBXN.S  said it has raised 60 million 
Swiss francs in debt through issuance of a fixed rate domestic 
straight bond.  UBXN.S  
    * Orpheee  ORPP.WA  narrowed its 2016 loss to 3.2 million 
francs from 10.4 million francs the year before. 
     
    ECONOMY  M-CH  
 
 
 (Reporting by Zurich newsroom) 
 ((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com)) 
  
((For Top News in a multimedia Web format on Eikon visit: 
https://emea1.views.cp.extranet.thomsonreuters.biz/Explorer/NEWSxTOPNEWS.aspx?group=SP_GROUP_001&page=SP_PAGE_001&pageName=FrontPage 
 FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON: 
     
 Daily Swiss stock market report in German................ .SDE  
 All SMI constituent stocks............................ 0#.SSMI   
 News on major Swiss stock price moves.................. CH-HOT  
 FTSE Eurotop 300 index................................  .FTEU3  
 DJ STOXX index........................................  .STOXX  
 Top 10 STOXX sectors.............................  .PGL.STOXXS   
 Top 10 EUROSTOXX sectors........................  .PGL.STOXXES  
 Top 10 Eurotop 300 sectors.......................  .PGL.FTEU3S  
 Top 25 European pct gainers...  .PG.PEUR , losers...  .PL.PEUR  
     
 Swiss mid-cap index      .SSMI   SMI futures            0#SMI:  
 Swiss all-share index    .SSHI   Market statistics   CH/STATS1  
 Swiss market digest      .AD.S   Sector overview    CH/SECTOR1  
 All Swiss news              CH   Swiss research news     CH-RCH    
 All equity news              E   
      
 INTERNET ADDRESSES:               
  
Swiss Exchange  www.swx.ch/      
Eurex   www.eurexchange.com 
STOXX Ltd         www.stoxx.com  
  
 SPEED GUIDES:  VX/EQUITY   EQUITY   EQUITY/NEWS1   EUR/EQUITY   
  SWITZERLAND   REUTERS  )) 
 
Keywords: MARKETS SWISS STOCKS/

Recent news on Newron Pharmaceuticals SpA

See all news